Citigroup Inc Bridge Bio Pharma, Inc. Call Options Transaction History

Citigroup Inc

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 12, 2024	SELL	$23.0 - $31.04 $917,700 - $1.24 Million	-39,900 Reduced 59.64%	27,000 $683,000
Q1 2024 May 10, 2024	BUY	$27.35 - $40.45 $273,500 - $404,500	10,000 Added 17.57%	66,900 $2.07 Million
Q4 2023 Feb 09, 2024	BUY	$24.02 - $43.89 $684,570 - $1.25 Million	28,500 Added 100.35%	56,900 $2.3 Million
Q3 2023 Nov 09, 2023	BUY	$16.89 - $35.01 $96,273 - $199,557	5,700 Added 25.11%	28,400 $748,000
Q1 2023 May 11, 2023	BUY	$7.17 - $18.55 $162,759 - $421,085	22,700 New	22,700 $376,000
Q3 2022 Nov 10, 2022	BUY	$7.94 - $12.36 $310,454 - $483,276	39,100 New	39,100 $389,000

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.47B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.